The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension
Identifieur interne : 001430 ( Main/Corpus ); précédent : 001429; suivant : 001431The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension
Auteurs : Anne Pavy-Le Traon ; Gerard Amarenco ; Susanne Duerr ; Horacio Kaufmann ; Heinz Lahrmann ; Stephanie R. Shaftman ; François Tison ; Gregor K. Wenning ; Christopher G. Goetz ; Werner Poewe ; Cristina Sampaio ; Anette Schrag ; Glenn T. Stebbins ; Olivier RascolSource :
- Movement Disorders [ 0885-3185 ] ; 2011-09.
English descriptors
- KwdEn :
Abstract
Orthostatic hypotension is defined as a blood pressure fall of > 20 mm Hg systolic and/or 10 mm Hg diastolic within 3 minutes of an upright position. The Movement Disorders Society commissioned a task force to assess existing clinical rating scales addressing symptoms of orthostatic hypotension in Parkinson's disease. Seven neurologists and a clinimetrician assessed each scale's previous use and critiqued its clinimetric properties. A scale was “recommended” if it had been applied to populations of patients with Parkinson's disease, with data on its use in studies beyond the group that developed the scale, and was found to be clinimetrically valid. A scale was considered “suggested” if it had been applied to Parkinson's disease, but only 1 of the other criteria was applied. A scale was “listed” if it met only 1 criterion. Symptoms of orthostatic hypotension are generally assessed in scales on wider autonomic or nonmotor symptoms. Some scales designed to detect orthostatic hypotension–related symptoms provide information on their severity: the AUTonomic SCale for Outcomes in PArkinson's Disease and the COMPosite Autonomic Symptom Scale met criteria for recommended with some limitations; the Novel Non‐Motor Symptoms Scale and the Orthostatic Grading Scale were classified as suggested. The Self‐completed Non‐Motor Symptoms Questionnaire for Parkinson's Disease was classified as suggested as a tool for screening orthostatic symptoms. However, these and the listed scales need further validation and application before they can be recommended for clinical use in patients with Parkinson's disease. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23742
Links to Exploration step
ISTEX:5CAAFB14AF843EFD116B3347796485E6379B2A85Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension</title><author><name sortKey="Pavy E Traon, Anne" sort="Pavy E Traon, Anne" uniqKey="Pavy E Traon A" first="Anne" last="Pavy-Le Traon">Anne Pavy-Le Traon</name><affiliation><mods:affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</mods:affiliation></affiliation></author><author><name sortKey="Amarenco, Gerard" sort="Amarenco, Gerard" uniqKey="Amarenco G" first="Gerard" last="Amarenco">Gerard Amarenco</name><affiliation><mods:affiliation>Service de Rééducation Neurologique et d'Explorations Périnéales, Rothschild Hospital, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Duerr, Susanne" sort="Duerr, Susanne" uniqKey="Duerr S" first="Susanne" last="Duerr">Susanne Duerr</name><affiliation><mods:affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</mods:affiliation></affiliation></author><author><name sortKey="Kaufmann, Horacio" sort="Kaufmann, Horacio" uniqKey="Kaufmann H" first="Horacio" last="Kaufmann">Horacio Kaufmann</name><affiliation><mods:affiliation>Department of Neurology, New York University, New York, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Lahrmann, Heinz" sort="Lahrmann, Heinz" uniqKey="Lahrmann H" first="Heinz" last="Lahrmann">Heinz Lahrmann</name><affiliation><mods:affiliation>Department of Neurology, Kaiser Franz Josef Hospital, Vienna, Austria</mods:affiliation></affiliation></author><author><name sortKey="Shaftman, Stephanie R" sort="Shaftman, Stephanie R" uniqKey="Shaftman S" first="Stephanie R." last="Shaftman">Stephanie R. Shaftman</name><affiliation><mods:affiliation>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA</mods:affiliation></affiliation></author><author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name><affiliation><mods:affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, University Hospital of Bordeaux, Pessac, France</mods:affiliation></affiliation></author><author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name><affiliation><mods:affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</mods:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><affiliation><mods:affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</mods:affiliation></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><mods:affiliation>Department of Neurology, Innsbruck Medical University, Innsbruck, Austria</mods:affiliation></affiliation></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name><affiliation><mods:affiliation>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine, Lisbon, Portugal</mods:affiliation></affiliation></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name><affiliation><mods:affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</mods:affiliation></affiliation></author><author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name><affiliation><mods:affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Clinical Pharmacology and Clinical Investigation Center, University Hospital and University of Toulouse III, Toulouse, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5CAAFB14AF843EFD116B3347796485E6379B2A85</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23742</idno><idno type="url">https://api.istex.fr/document/5CAAFB14AF843EFD116B3347796485E6379B2A85/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001430</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension</title><author><name sortKey="Pavy E Traon, Anne" sort="Pavy E Traon, Anne" uniqKey="Pavy E Traon A" first="Anne" last="Pavy-Le Traon">Anne Pavy-Le Traon</name><affiliation><mods:affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</mods:affiliation></affiliation></author><author><name sortKey="Amarenco, Gerard" sort="Amarenco, Gerard" uniqKey="Amarenco G" first="Gerard" last="Amarenco">Gerard Amarenco</name><affiliation><mods:affiliation>Service de Rééducation Neurologique et d'Explorations Périnéales, Rothschild Hospital, Paris, France</mods:affiliation></affiliation></author><author><name sortKey="Duerr, Susanne" sort="Duerr, Susanne" uniqKey="Duerr S" first="Susanne" last="Duerr">Susanne Duerr</name><affiliation><mods:affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</mods:affiliation></affiliation></author><author><name sortKey="Kaufmann, Horacio" sort="Kaufmann, Horacio" uniqKey="Kaufmann H" first="Horacio" last="Kaufmann">Horacio Kaufmann</name><affiliation><mods:affiliation>Department of Neurology, New York University, New York, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Lahrmann, Heinz" sort="Lahrmann, Heinz" uniqKey="Lahrmann H" first="Heinz" last="Lahrmann">Heinz Lahrmann</name><affiliation><mods:affiliation>Department of Neurology, Kaiser Franz Josef Hospital, Vienna, Austria</mods:affiliation></affiliation></author><author><name sortKey="Shaftman, Stephanie R" sort="Shaftman, Stephanie R" uniqKey="Shaftman S" first="Stephanie R." last="Shaftman">Stephanie R. Shaftman</name><affiliation><mods:affiliation>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA</mods:affiliation></affiliation></author><author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name><affiliation><mods:affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, University Hospital of Bordeaux, Pessac, France</mods:affiliation></affiliation></author><author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name><affiliation><mods:affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</mods:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><affiliation><mods:affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</mods:affiliation></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><mods:affiliation>Department of Neurology, Innsbruck Medical University, Innsbruck, Austria</mods:affiliation></affiliation></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name><affiliation><mods:affiliation>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine, Lisbon, Portugal</mods:affiliation></affiliation></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name><affiliation><mods:affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</mods:affiliation></affiliation></author><author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name><affiliation><mods:affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Clinical Pharmacology and Clinical Investigation Center, University Hospital and University of Toulouse III, Toulouse, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-09">2011-09</date><biblScope unit="volume">26</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1985">1985</biblScope><biblScope unit="page" to="1992">1992</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">5CAAFB14AF843EFD116B3347796485E6379B2A85</idno><idno type="DOI">10.1002/mds.23742</idno><idno type="ArticleID">MDS23742</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>autonomic failure</term><term>clinimetrics</term><term>orthostatic hypotension</term><term>orthostatic symptoms</term><term>rating scales</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Orthostatic hypotension is defined as a blood pressure fall of > 20 mm Hg systolic and/or 10 mm Hg diastolic within 3 minutes of an upright position. The Movement Disorders Society commissioned a task force to assess existing clinical rating scales addressing symptoms of orthostatic hypotension in Parkinson's disease. Seven neurologists and a clinimetrician assessed each scale's previous use and critiqued its clinimetric properties. A scale was “recommended” if it had been applied to populations of patients with Parkinson's disease, with data on its use in studies beyond the group that developed the scale, and was found to be clinimetrically valid. A scale was considered “suggested” if it had been applied to Parkinson's disease, but only 1 of the other criteria was applied. A scale was “listed” if it met only 1 criterion. Symptoms of orthostatic hypotension are generally assessed in scales on wider autonomic or nonmotor symptoms. Some scales designed to detect orthostatic hypotension–related symptoms provide information on their severity: the AUTonomic SCale for Outcomes in PArkinson's Disease and the COMPosite Autonomic Symptom Scale met criteria for recommended with some limitations; the Novel Non‐Motor Symptoms Scale and the Orthostatic Grading Scale were classified as suggested. The Self‐completed Non‐Motor Symptoms Questionnaire for Parkinson's Disease was classified as suggested as a tool for screening orthostatic symptoms. However, these and the listed scales need further validation and application before they can be recommended for clinical use in patients with Parkinson's disease. © 2011 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Anne Pavy‐Le Traon MD, PhD</name><affiliations><json:string>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</json:string></affiliations></json:item><json:item><name>Gerard Amarenco MD</name><affiliations><json:string>Service de Rééducation Neurologique et d'Explorations Périnéales, Rothschild Hospital, Paris, France</json:string></affiliations></json:item><json:item><name>Susanne Duerr MD</name><affiliations><json:string>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</json:string></affiliations></json:item><json:item><name>Horacio Kaufmann MD</name><affiliations><json:string>Department of Neurology, New York University, New York, New York, USA</json:string></affiliations></json:item><json:item><name>Heinz Lahrmann MD</name><affiliations><json:string>Department of Neurology, Kaiser Franz Josef Hospital, Vienna, Austria</json:string></affiliations></json:item><json:item><name>Stephanie R. Shaftman MSc, MS</name><affiliations><json:string>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA</json:string></affiliations></json:item><json:item><name>François Tison MD, PhD</name><affiliations><json:string>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</json:string><json:string>Department of Neurology, University Hospital of Bordeaux, Pessac, France</json:string></affiliations></json:item><json:item><name>Gregor K. Wenning MD, MSc, PhD</name><affiliations><json:string>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</json:string></affiliations></json:item><json:item><name>Christopher G. Goetz MD</name><affiliations><json:string>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</json:string></affiliations></json:item><json:item><name>Werner Poewe MD</name><affiliations><json:string>Department of Neurology, Innsbruck Medical University, Innsbruck, Austria</json:string></affiliations></json:item><json:item><name>Cristina Sampaio MD</name><affiliations><json:string>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine, Lisbon, Portugal</json:string></affiliations></json:item><json:item><name>Anette Schrag FRCP, PhD</name><affiliations><json:string>Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Glenn T. Stebbins PhD</name><affiliations><json:string>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</json:string></affiliations></json:item><json:item><name>Olivier Rascol MD</name><affiliations><json:string>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</json:string><json:string>Department of Clinical Pharmacology and Clinical Investigation Center, University Hospital and University of Toulouse III, Toulouse, France</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>orthostatic hypotension</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>autonomic failure</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>rating scales</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>clinimetrics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>orthostatic symptoms</value></json:item></subject><articleId><json:string>MDS23742</json:string></articleId><language><json:string>eng</json:string></language><abstract>Orthostatic hypotension is defined as a blood pressure fall of > 20 mm Hg systolic and/or 10 mm Hg diastolic within 3 minutes of an upright position. The Movement Disorders Society commissioned a task force to assess existing clinical rating scales addressing symptoms of orthostatic hypotension in Parkinson's disease. Seven neurologists and a clinimetrician assessed each scale's previous use and critiqued its clinimetric properties. A scale was “recommended” if it had been applied to populations of patients with Parkinson's disease, with data on its use in studies beyond the group that developed the scale, and was found to be clinimetrically valid. A scale was considered “suggested” if it had been applied to Parkinson's disease, but only 1 of the other criteria was applied. A scale was “listed” if it met only 1 criterion. Symptoms of orthostatic hypotension are generally assessed in scales on wider autonomic or nonmotor symptoms. Some scales designed to detect orthostatic hypotension–related symptoms provide information on their severity: the AUTonomic SCale for Outcomes in PArkinson's Disease and the COMPosite Autonomic Symptom Scale met criteria for recommended with some limitations; the Novel Non‐Motor Symptoms Scale and the Orthostatic Grading Scale were classified as suggested. The Self‐completed Non‐Motor Symptoms Questionnaire for Parkinson's Disease was classified as suggested as a tool for screening orthostatic symptoms. However, these and the listed scales need further validation and application before they can be recommended for clinical use in patients with Parkinson's disease. © 2011 Movement Disorder Society</abstract><qualityIndicators><score>7.51</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>6</keywordCount><abstractCharCount>1649</abstractCharCount><pdfWordCount>4582</pdfWordCount><pdfCharCount>30099</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>244</abstractWordCount></qualityIndicators><title>The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension</title><genre><json:string>review-article</json:string></genre><host><volume>26</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>8</total><last>1992</last><first>1985</first></pages><issn><json:string>0885-3185</json:string></issn><issue>11</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1002/mds.23742</json:string></doi><id>5CAAFB14AF843EFD116B3347796485E6379B2A85</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/5CAAFB14AF843EFD116B3347796485E6379B2A85/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/5CAAFB14AF843EFD116B3347796485E6379B2A85/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/5CAAFB14AF843EFD116B3347796485E6379B2A85/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2011</date></publicationStmt><notesStmt><note type="content">*Relevant conflicts of interest/financial disclosures: Nothing to report.</note><note type="content">*Full financial disclosures and author roles may be found in the online version of this article.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension</title><author><persName><forename type="first">Anne</forename><surname>Pavy‐Le Traon</surname></persName><roleName type="degree">MD, PhD</roleName><note type="correspondence"><p>Correspondence: Reference Centre for MSA, Department of Neurology, Hôpital Purpan, Pavillon Riser, 31059 Toulouse cedex 9, France</p></note><affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</affiliation></author><author><persName><forename type="first">Gerard</forename><surname>Amarenco</surname></persName><roleName type="degree">MD</roleName><affiliation>Service de Rééducation Neurologique et d'Explorations Périnéales, Rothschild Hospital, Paris, France</affiliation></author><author><persName><forename type="first">Susanne</forename><surname>Duerr</surname></persName><roleName type="degree">MD</roleName><affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</affiliation></author><author><persName><forename type="first">Horacio</forename><surname>Kaufmann</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, New York University, New York, New York, USA</affiliation></author><author><persName><forename type="first">Heinz</forename><surname>Lahrmann</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Kaiser Franz Josef Hospital, Vienna, Austria</affiliation></author><author><persName><forename type="first">Stephanie R.</forename><surname>Shaftman</surname></persName><roleName type="degree">MSc, MS</roleName><affiliation>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA</affiliation></author><author><persName><forename type="first">François</forename><surname>Tison</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</affiliation><affiliation>Department of Neurology, University Hospital of Bordeaux, Pessac, France</affiliation></author><author><persName><forename type="first">Gregor K.</forename><surname>Wenning</surname></persName><roleName type="degree">MD, MSc, PhD</roleName><affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</affiliation></author><author><persName><forename type="first">Christopher G.</forename><surname>Goetz</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</affiliation></author><author><persName><forename type="first">Werner</forename><surname>Poewe</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Innsbruck Medical University, Innsbruck, Austria</affiliation></author><author><persName><forename type="first">Cristina</forename><surname>Sampaio</surname></persName><roleName type="degree">MD</roleName><affiliation>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine, Lisbon, Portugal</affiliation></author><author><persName><forename type="first">Anette</forename><surname>Schrag</surname></persName><roleName type="degree">FRCP, PhD</roleName><affiliation>Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom</affiliation></author><author><persName><forename type="first">Glenn T.</forename><surname>Stebbins</surname></persName><roleName type="degree">PhD</roleName><affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</affiliation></author><author><persName><forename type="first">Olivier</forename><surname>Rascol</surname></persName><roleName type="degree">MD</roleName><affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</affiliation><affiliation>Department of Clinical Pharmacology and Clinical Investigation Center, University Hospital and University of Toulouse III, Toulouse, France</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-09"></date><biblScope unit="volume">26</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1985">1985</biblScope><biblScope unit="page" to="1992">1992</biblScope></imprint></monogr><idno type="istex">5CAAFB14AF843EFD116B3347796485E6379B2A85</idno><idno type="DOI">10.1002/mds.23742</idno><idno type="ArticleID">MDS23742</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2011</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Orthostatic hypotension is defined as a blood pressure fall of > 20 mm Hg systolic and/or 10 mm Hg diastolic within 3 minutes of an upright position. The Movement Disorders Society commissioned a task force to assess existing clinical rating scales addressing symptoms of orthostatic hypotension in Parkinson's disease. Seven neurologists and a clinimetrician assessed each scale's previous use and critiqued its clinimetric properties. A scale was “recommended” if it had been applied to populations of patients with Parkinson's disease, with data on its use in studies beyond the group that developed the scale, and was found to be clinimetrically valid. A scale was considered “suggested” if it had been applied to Parkinson's disease, but only 1 of the other criteria was applied. A scale was “listed” if it met only 1 criterion. Symptoms of orthostatic hypotension are generally assessed in scales on wider autonomic or nonmotor symptoms. Some scales designed to detect orthostatic hypotension–related symptoms provide information on their severity: the AUTonomic SCale for Outcomes in PArkinson's Disease and the COMPosite Autonomic Symptom Scale met criteria for recommended with some limitations; the Novel Non‐Motor Symptoms Scale and the Orthostatic Grading Scale were classified as suggested. The Self‐completed Non‐Motor Symptoms Questionnaire for Parkinson's Disease was classified as suggested as a tool for screening orthostatic symptoms. However, these and the listed scales need further validation and application before they can be recommended for clinical use in patients with Parkinson's disease. © 2011 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>orthostatic hypotension</term></item><item><term>Parkinson's disease</term></item><item><term>autonomic failure</term></item><item><term>rating scales</term></item><item><term>clinimetrics</term></item><item><term>orthostatic symptoms</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-09-11">Received</change><change when="2011-03-11">Registration</change><change when="2011-09">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/5CAAFB14AF843EFD116B3347796485E6379B2A85/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="110"><doi origin="wiley" registered="yes">10.1002/mds.v26.11</doi><numberingGroup><numbering type="journalVolume" number="26">26</numbering><numbering type="journalIssue">11</numbering></numberingGroup><coverDate startDate="2011-09">September 2011</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="60" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23742</doi><idGroup><id type="unit" value="MDS23742"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">Copyright © 2011 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2009-09-11"></event><event type="manuscriptRevised" date="2011-03-09"></event><event type="manuscriptAccepted" date="2011-03-11"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.10 mode:FullText" date="2011-09-19"></event><event type="publishedOnlineEarlyUnpaginated" date="2011-05-05"></event><event type="firstOnline" date="2011-05-05"></event><event type="publishedOnlineFinalForm" date="2011-09-19"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">1985</numbering><numbering type="pageLast">1992</numbering></numberingGroup><correspondenceTo>Reference Centre for MSA, Department of Neurology, Hôpital Purpan, Pavillon Riser, 31059 Toulouse cedex 9, France</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23742.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="3"></count><count type="referenceTotal" number="46"></count><count type="wordTotal" number="6211"></count></countGroup><titleGroup><title type="main" xml:lang="en">The <i>Movement</i> Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension<link href="#fn1"></link><link href="#fn2"></link></title><title type="short" xml:lang="en">Dysautonomia Rating Scales in PD–OH Symptoms</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Anne</givenNames><familyName>Pavy‐Le Traon</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email normalForm="pavy-letraon.a@chu-toulouse.fr">pavy‐letraon.a@chu‐toulouse.fr</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Gerard</givenNames><familyName>Amarenco</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Susanne</givenNames><familyName>Duerr</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Horacio</givenNames><familyName>Kaufmann</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Heinz</givenNames><familyName>Lahrmann</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Stephanie R.</givenNames><familyName>Shaftman</familyName><degrees>MSc, MS</degrees></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af1 #af7"><personName><givenNames>François</givenNames><familyName>Tison</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au8" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Gregor K.</givenNames><familyName>Wenning</familyName><degrees>MD, MSc, PhD</degrees></personName></creator><creator xml:id="au9" creatorRole="author" affiliationRef="#af8"><personName><givenNames>Christopher G.</givenNames><familyName>Goetz</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au10" creatorRole="author" affiliationRef="#af9"><personName><givenNames>Werner</givenNames><familyName>Poewe</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au11" creatorRole="author" affiliationRef="#af10"><personName><givenNames>Cristina</givenNames><familyName>Sampaio</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au12" creatorRole="author" affiliationRef="#af11"><personName><givenNames>Anette</givenNames><familyName>Schrag</familyName><degrees>FRCP, PhD</degrees></personName></creator><creator xml:id="au13" creatorRole="author" affiliationRef="#af8"><personName><givenNames>Glenn T.</givenNames><familyName>Stebbins</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au14" creatorRole="author" affiliationRef="#af1 #af12"><personName><givenNames>Olivier</givenNames><familyName>Rascol</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="FR" type="organization"><unparsedAffiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="FR" type="organization"><unparsedAffiliation>Service de Rééducation Neurologique et d'Explorations Périnéales, Rothschild Hospital, Paris, France</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="AT" type="organization"><unparsedAffiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, New York University, New York, New York, USA</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="AT" type="organization"><unparsedAffiliation>Department of Neurology, Kaiser Franz Josef Hospital, Vienna, Austria</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="US" type="organization"><unparsedAffiliation>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA</unparsedAffiliation></affiliation><affiliation xml:id="af7" countryCode="FR" type="organization"><unparsedAffiliation>Department of Neurology, University Hospital of Bordeaux, Pessac, France</unparsedAffiliation></affiliation><affiliation xml:id="af8" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</unparsedAffiliation></affiliation><affiliation xml:id="af9" countryCode="AT" type="organization"><unparsedAffiliation>Department of Neurology, Innsbruck Medical University, Innsbruck, Austria</unparsedAffiliation></affiliation><affiliation xml:id="af10" countryCode="PT" type="organization"><unparsedAffiliation>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine, Lisbon, Portugal</unparsedAffiliation></affiliation><affiliation xml:id="af11" countryCode="GB" type="organization"><unparsedAffiliation>Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af12" countryCode="FR" type="organization"><unparsedAffiliation>Department of Clinical Pharmacology and Clinical Investigation Center, University Hospital and University of Toulouse III, Toulouse, France</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">orthostatic hypotension</keyword><keyword xml:id="kwd2">Parkinson's disease</keyword><keyword xml:id="kwd3">autonomic failure</keyword><keyword xml:id="kwd4">rating scales</keyword><keyword xml:id="kwd5">clinimetrics</keyword><keyword xml:id="kwd6">orthostatic symptoms</keyword></keywordGroup><supportingInformation><p> Additional Supporting Information may be found in the online version of this article. </p><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds23742:MDS_23742_sm_SuppMaterials1"></mediaResource><caption>Supporting Information Materials 1.1.</caption></supportingInfoItem><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds23742:MDS_23742_sm_SuppMaterials1"></mediaResource><caption>Supporting Information Materials 1.2.</caption></supportingInfoItem><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds23742:MDS_23742_sm_SuppMaterials2"></mediaResource><caption>Supporting Information Materials 2</caption></supportingInfoItem><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds23742:MDS_23742_sm_SuppMaterials3"></mediaResource><caption>Supporting Information Materials 3</caption></supportingInfoItem></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Orthostatic hypotension is defined as a blood pressure fall of > 20 mm Hg systolic and/or 10 mm Hg diastolic within 3 minutes of an upright position. The <i>Movement</i> Disorders Society commissioned a task force to assess existing clinical rating scales addressing symptoms of orthostatic hypotension in Parkinson's disease. Seven neurologists and a clinimetrician assessed each scale's previous use and critiqued its clinimetric properties. A scale was “recommended” if it had been applied to populations of patients with Parkinson's disease, with data on its use in studies beyond the group that developed the scale, and was found to be clinimetrically valid. A scale was considered “suggested” if it had been applied to Parkinson's disease, but only 1 of the other criteria was applied. A scale was “listed” if it met only 1 criterion. Symptoms of orthostatic hypotension are generally assessed in scales on wider autonomic or nonmotor symptoms. Some scales designed to detect orthostatic hypotension–related symptoms provide information on their severity: the AUTonomic SCale for Outcomes in PArkinson's Disease and the COMPosite Autonomic Symptom Scale met criteria for recommended with some limitations; the Novel Non‐Motor Symptoms Scale and the Orthostatic Grading Scale were classified as suggested. The Self‐completed Non‐Motor Symptoms Questionnaire for Parkinson's Disease was classified as suggested as a tool for screening orthostatic symptoms. However, these and the listed scales need further validation and application before they can be recommended for clinical use in patients with Parkinson's disease. © 2011 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p><b>Relevant conflicts of interest/financial disclosures</b>: Nothing to report.</p></note><note xml:id="fn2"><p>Full financial disclosures and author roles may be found in the online version of this article.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Dysautonomia Rating Scales in PD–OH Symptoms</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>The</title></titleInfo><name type="personal"><namePart type="given">Anne</namePart><namePart type="family">Pavy‐Le Traon</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</affiliation><description>Correspondence: Reference Centre for MSA, Department of Neurology, Hôpital Purpan, Pavillon Riser, 31059 Toulouse cedex 9, France</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gerard</namePart><namePart type="family">Amarenco</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Service de Rééducation Neurologique et d'Explorations Périnéales, Rothschild Hospital, Paris, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Susanne</namePart><namePart type="family">Duerr</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Horacio</namePart><namePart type="family">Kaufmann</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, New York University, New York, New York, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Heinz</namePart><namePart type="family">Lahrmann</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Kaiser Franz Josef Hospital, Vienna, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Stephanie R.</namePart><namePart type="family">Shaftman</namePart><namePart type="termsOfAddress">MSc, MS</namePart><affiliation>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">François</namePart><namePart type="family">Tison</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</affiliation><affiliation>Department of Neurology, University Hospital of Bordeaux, Pessac, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gregor K.</namePart><namePart type="family">Wenning</namePart><namePart type="termsOfAddress">MD, MSc, PhD</namePart><affiliation>Division of Clinical Neurobiology, Medical University, Innsbruck, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Christopher G.</namePart><namePart type="family">Goetz</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Werner</namePart><namePart type="family">Poewe</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Innsbruck Medical University, Innsbruck, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Cristina</namePart><namePart type="family">Sampaio</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine, Lisbon, Portugal</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Anette</namePart><namePart type="family">Schrag</namePart><namePart type="termsOfAddress">FRCP, PhD</namePart><affiliation>Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Glenn T.</namePart><namePart type="family">Stebbins</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Neurological Services, Rush University School of Medicine, Chicago, Illinois, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Olivier</namePart><namePart type="family">Rascol</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Reference Centre for MSA, University Hospital, INSERM U1048 Eq8, Toulouse, France, and Explorations Fonctionnelles, University Hospital, Brest, France</affiliation><affiliation>Department of Clinical Pharmacology and Clinical Investigation Center, University Hospital and University of Toulouse III, Toulouse, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2011-09</dateIssued><dateCaptured encoding="w3cdtf">2009-09-11</dateCaptured><dateValid encoding="w3cdtf">2011-03-11</dateValid><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">3</extent><extent unit="references">46</extent><extent unit="words">6211</extent></physicalDescription><abstract lang="en">Orthostatic hypotension is defined as a blood pressure fall of > 20 mm Hg systolic and/or 10 mm Hg diastolic within 3 minutes of an upright position. The Movement Disorders Society commissioned a task force to assess existing clinical rating scales addressing symptoms of orthostatic hypotension in Parkinson's disease. Seven neurologists and a clinimetrician assessed each scale's previous use and critiqued its clinimetric properties. A scale was “recommended” if it had been applied to populations of patients with Parkinson's disease, with data on its use in studies beyond the group that developed the scale, and was found to be clinimetrically valid. A scale was considered “suggested” if it had been applied to Parkinson's disease, but only 1 of the other criteria was applied. A scale was “listed” if it met only 1 criterion. Symptoms of orthostatic hypotension are generally assessed in scales on wider autonomic or nonmotor symptoms. Some scales designed to detect orthostatic hypotension–related symptoms provide information on their severity: the AUTonomic SCale for Outcomes in PArkinson's Disease and the COMPosite Autonomic Symptom Scale met criteria for recommended with some limitations; the Novel Non‐Motor Symptoms Scale and the Orthostatic Grading Scale were classified as suggested. The Self‐completed Non‐Motor Symptoms Questionnaire for Parkinson's Disease was classified as suggested as a tool for screening orthostatic symptoms. However, these and the listed scales need further validation and application before they can be recommended for clinical use in patients with Parkinson's disease. © 2011 Movement Disorder Society</abstract><note type="content">*Relevant conflicts of interest/financial disclosures: Nothing to report.</note><note type="content">*Full financial disclosures and author roles may be found in the online version of this article.</note><subject lang="en"><genre>Keywords</genre><topic>orthostatic hypotension</topic><topic>Parkinson's disease</topic><topic>autonomic failure</topic><topic>rating scales</topic><topic>clinimetrics</topic><topic>orthostatic symptoms</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><note type="content"> Additional Supporting Information may be found in the online version of this article.Supporting Info Item: Supporting Information Materials 1.1. - Supporting Information Materials 1.2. - Supporting Information Materials 2 - Supporting Information Materials 3 - </note><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><detail type="issue"><caption>no.</caption><number>11</number></detail><extent unit="pages"><start>1985</start><end>1992</end><total>8</total></extent></part></relatedItem><identifier type="istex">5CAAFB14AF843EFD116B3347796485E6379B2A85</identifier><identifier type="DOI">10.1002/mds.23742</identifier><identifier type="ArticleID">MDS23742</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2011 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001430 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001430 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:5CAAFB14AF843EFD116B3347796485E6379B2A85
|texte= The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension
}}
| This area was generated with Dilib version V0.6.23. |  |